تحميل...
Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits
Nonsteroidal anti-inflammatory drugs (NSAIDs) are often coadministered with proton-pump inhibitors (PPIs) to reduce NSAID-induced gastrointestinal (GI) adverse events. This coadministration is generally regarded as safe, and is included in many of the guidelines on NSAID prescription. However, recen...
محفوظ في:
| الحاوية / القاعدة: | J Pain Res |
|---|---|
| المؤلفون الرئيسيون: | , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Dove Medical Press
2018
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5817415/ https://ncbi.nlm.nih.gov/pubmed/29491719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S156938 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|